On Friday, Labcorp Holdings received an upgrade to its Relative Strength (RS) Rating, from 66 to 78.
Can You Really Time The Stock Market?
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an RS Rating of above 80 in the early stages of their moves. See if Labcorp Holdings can continue to rebound and clear that threshold.
While the stock is not near an ideal entry right now, see if it is able to form and break out from a proper base.
Earnings grew 10% last quarter, up from 4% in the prior report. Revenue also increased, from 5% to 10%.
Labcorp Holdings holds the No. 7 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Stevanato Group and Progyny are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
